CJC-1295 2mg

Description

CJC-1295 2mg is supplied as a lyophilized modified GHRH analog for controlled laboratory investigation. CJC-1295 with DAC is used in preclinical research models studying growth-hormone release dynamics, GHRH receptor activity, extended peptide half-life behavior, endocrine response markers, and metabolic signaling endpoints.

Research positioning

This product is intended for qualified laboratory research workflows only. It is not supplied for personal use, performance use, recovery use, clinical use, compounding, human administration, veterinary administration, diagnosis, treatment, mitigation, or prevention of disease.

Product specifications

• Compound: CJC-1295 with DAC
• Format: Lyophilized powder
• Fill: 2mg per vial
• Testing: 99%+ HPLC purity verification
• Storage: Refrigerated storage recommended at 2-8°C
• Intended use: Laboratory research only

Documentation

Batch documentation is available on request while the downloadable COA library is being finalized. View current documentation status on the Lab Results & Batch Documentation page, or contact support with the product name, order number if applicable, and batch reference when available. Documentation may include batch reference, purity verification, testing method, release status, and storage guidance.

Research-use notice

For research use only. Not for human or veterinary use. Buyer is responsible for compliance with local laws, institutional rules, and applicable research ethics requirements.